CT45A2

Q-omics provides the consensus-scored CT45A2 profile across patient tissues and cancer cell-line models. CT45A2 expression is associated with patient survival in 1 of 34 cancer types, with the highest sampling consensus in ESCA. Additionally, CT45A2 RNA expression shows 162 significant gene co-expression associations, with the highest sampling consensus in ESCA. Together, these results highlight ESCA as cancer lineages where CT45A2 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.

Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.

Survival associations

This table summarizes CT45A2 survival associations across molecular data types. CT45A2 RNA expression shows survival associations in the most cancer types (1). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.

CT45A2 data type	Survival analysis	Lineage consensus	Lineage of highest sampling consensus
RNA	Kaplan–Meier	1	ESCA (6)	view →

This table ranks reproducible CT45A2 RNA expression–survival associations across cancer types. High CT45A2 expression shows unfavorable associations in ESCA. The ESCA Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p = .047). Together, the overview and detailed table identify ESCA as the clearest survival context for CT45A2 RNA expression.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
ESCA	OS	Tertile	All	0.570	0.700	.047	6	view →

Pink = unfavorable, green = favorable. all 1 lineages →

CT45A2-ESCA (OS)

Explore this curve interactively →